美国加州圣卡洛斯——百济神州有限公司(纳斯达克代码:ONC;香港联交所代码:06160;上交所代码:688235)是一家全球肿瘤治疗创新公司,今日宣布欧洲药品管理局(EMA)人用药品委员会(CHMP)发布积极意见,推荐批准百悦泽®(泽布替尼)新的薄膜包衣片剂剂型用于所有已获批适应症。欧盟委员会将对CHMP的积极意见进行审评,如通过批准,片剂剂型在欧盟和欧洲经济区国家挪威和冰岛上市。我们一直致力于将...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.